The Next Step in Type B Aortic Dissection

Abstract
In their manuscript, “Mid-term survival after thoracic endovascular aortic repair by indication in the Medicare population,” Ho and colleagues 1 Ho V.T. Itoga N.K. Tran K. et al. Mid-term survival after thoracic endovascular aortic repair by indication in the Medicare population. J Am Coll Surg. 2021; 232 : 46-53 Abstract Full Text Full Text PDF PubMed Scopus (1) Google Scholar present mid-term outcomes data in terms of mortality and reintervention rates for patients undergoing thoracic endovascular aortic repair (TEVAR) for aortic aneurysm, dissection, and aortic traumatic injury. The aim of their analysis was to compare the mid-term outcomes stratified by aortic pathology classification. Although Ho and colleagues acknowledge the limitations of a retrospective analysis of the Medicare dataset, their study provides insight into the mortality associated with TEVAR for multiple aortic pathologies. It is novel in that it attempts to characterize the differential outcomes of TEVAR based on indication.